Jorge R. Taborga Sells 19,796 Shares of Omnicell, Inc. (OMCL) Stock

Omnicell, Inc. (NASDAQ:OMCL) EVP Jorge R. Taborga sold 19,796 shares of the business’s stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $83.86, for a total value of $1,660,092.56. Following the sale, the executive vice president now directly owns 36,156 shares in the company, valued at approximately $3,032,042.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

NASDAQ:OMCL traded down $0.03 during trading hours on Tuesday, hitting $83.95. 274,200 shares of the stock traded hands, compared to its average volume of 343,503. The company has a quick ratio of 1.45, a current ratio of 1.94 and a debt-to-equity ratio of 0.20. Omnicell, Inc. has a fifty-two week low of $41.59 and a fifty-two week high of $86.87. The company has a market cap of $3.29 billion, a P/E ratio of 54.87, a price-to-earnings-growth ratio of 4.01 and a beta of 1.18.

Get Omnicell alerts:

Omnicell (NASDAQ:OMCL) last announced its earnings results on Thursday, February 7th. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.16. Omnicell had a net margin of 4.79% and a return on equity of 9.31%. The company had revenue of $211.75 million for the quarter, compared to the consensus estimate of $215.41 million. During the same period in the previous year, the business earned $0.55 EPS. The company’s revenue was up 7.8% on a year-over-year basis. Equities research analysts anticipate that Omnicell, Inc. will post 1.83 earnings per share for the current year.

A number of large investors have recently made changes to their positions in the business. Geode Capital Management LLC raised its stake in Omnicell by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 442,184 shares of the company’s stock valued at $27,079,000 after purchasing an additional 32,512 shares during the period. Norges Bank purchased a new position in shares of Omnicell during the 4th quarter valued at $12,125,000. O Brien Greene & Co. Inc purchased a new position in shares of Omnicell during the 4th quarter valued at $374,000. Amalgamated Bank purchased a new position in shares of Omnicell during the 4th quarter valued at $373,000. Finally, Millennium Management LLC grew its holdings in shares of Omnicell by 182.1% during the 4th quarter. Millennium Management LLC now owns 25,354 shares of the company’s stock valued at $1,553,000 after acquiring an additional 56,254 shares in the last quarter. 99.89% of the stock is currently owned by institutional investors.

OMCL has been the topic of several recent analyst reports. Zacks Investment Research cut Omnicell from a “hold” rating to a “sell” rating in a report on Friday, February 15th. Oppenheimer boosted their target price on Omnicell to $86.00 and gave the stock an “outperform” rating in a report on Friday, December 7th. Piper Jaffray Companies reissued a “neutral” rating and set a $70.00 target price on shares of Omnicell in a report on Friday, February 8th. They noted that the move was a valuation call. Cantor Fitzgerald reissued an “overweight” rating and set a $80.00 target price (up previously from $70.00) on shares of Omnicell in a report on Thursday, December 6th. Finally, BidaskClub raised Omnicell from a “hold” rating to a “buy” rating in a report on Wednesday, February 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $76.56.

ILLEGAL ACTIVITY WARNING: “Jorge R. Taborga Sells 19,796 Shares of Omnicell, Inc. (OMCL) Stock” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/4216550/jorge-r-taborga-sells-19796-shares-of-omnicell-inc-omcl-stock.html.

About Omnicell

Omnicell, Inc provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications.

Featured Article: Why do commodities matter?